Case_id: case_1166
Case_description: 
A 15-year-old girl is brought to the physician by her mother because of worsening grades over the past year. Since she started high school one year ago, her academic performance has decreased. She also has had difficulty finding friends at the new school. She is afraid that her classmates will make fun of her and think that she is “stupid.” One month ago, when she had to give a presentation, she could not stop wondering how her classmates were going to react if she said something wrong. During the presentation, her heart started racing and she became flushed. Since this event, she avoids saying anything in class. She spends her breaks in the restroom because she is worried that nobody will talk to her. Physical and neurologic examinations show no abnormalities. On mental status examination, the girl avoids eye contact and appears uncomfortable and anxious. Which of the following is the most appropriate pharmacotherapy for this patient's condition?
Options: 
1. Clomipramine
2. Phenelzine
3. Clonazepam
4. Fluoxetine
5. Propranolol
Correct Answer: Fluoxetine

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 4 (Fluoxetine)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient Information:** 15-year-old female high school student.  
- **Chief Complaint:** Worsening academic performance over the past year.  
- **Key Clinical Manifestations:**  
  - Decline in grades since starting high school one year ago.  
  - Difficulty making friends and fear of negative evaluation by classmates.  
  - Acute anxiety episode during a presentation one month ago, characterized by heart racing and flushing.  
  - Subsequent avoidance of class participation and social interactions, preferring to isolate in the restroom.  
  - Mental status examination reveals avoidance of eye contact, discomfort, and anxiety.  
- **Physical and Neurological Findings:** No abnormalities detected.

**2. Analysis of Clinical Features**  
The patient exhibits a persistent fear of negative evaluation in social settings, leading to avoidance behaviors that impair her academic and social functioning. The acute anxiety episode during a presentation, marked by physiological symptoms (tachycardia, flushing), is indicative of situational anxiety. The one-month duration and the impact on her daily activities suggest a chronic anxiety disorder rather than a transient reaction. The absence of physical or neurological abnormalities supports a primary psychiatric condition. Her symptoms align with those of Social Anxiety Disorder (Social Phobia), characterized by intense fear of social situations where one may be scrutinized.

**3. Differential Diagnosis Analysis**  
- **Clomipramine (Option 1):** A tricyclic antidepressant primarily used for Obsessive-Compulsive Disorder (OCD). While it has efficacy in anxiety disorders, SSRIs are preferred as first-line treatments for Social Anxiety Disorder.  
- **Phenelzine (Option 2):** A Monoamine Oxidase Inhibitor (MAOI) used for atypical depression. Its side effect profile and dietary restrictions make it less suitable for first-line treatment of anxiety disorders.  
- **Clonazepam (Option 3):** A benzodiazepine effective for acute anxiety relief. However, due to risks of dependence and tolerance, it is not recommended for long-term management of Social Anxiety Disorder.  
- **Fluoxetine (Option 4):** A Selective Serotonin Reuptake Inhibitor (SSRI) that is FDA-approved for Social Anxiety Disorder. SSRIs like fluoxetine are considered first-line pharmacotherapy due to their efficacy and favorable side effect profile.  
- **Propranolol (Option 5):** A beta-blocker used for situational anxiety, such as performance anxiety. It provides symptomatic relief for specific instances but does not address the underlying persistent anxiety disorder.

**4. Final Selection**  
**My final selection is: Option 4 (Fluoxetine)(氟西汀)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 4 (Fluoxetine)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A 15-year-old girl presents with declining academic performance, social withdrawal, and anxiety-related symptoms over the past year.  
- Key symptoms include fear of peer judgment, avoidance of speaking in class, hiding in restrooms during breaks, and physiological reactions (tachycardia, flushing) during a recent presentation.  
- Mental status examination reveals anxiety, avoidance of eye contact, and discomfort in social settings.  

**2. Analysis of Clinical Features**  
- **Timeline**: Symptoms began after starting high school, suggesting a social/environmental trigger. The panic-like episode during a presentation marks a turning point, leading to avoidance behaviors.  
- **Symptoms**: The fear of negative evaluation, social avoidance, and physiological arousal align with social anxiety disorder (SAD). The avoidance of speaking and withdrawal from peers indicate functional impairment.  
- **Exclusion of Organic Causes**: Normal physical and neurologic exams rule out medical or neurological etiologies. Anxiety is the primary driver of symptoms, supported by the mental status findings.  

**3. Differential Diagnosis Analysis**  
- **Clomipramine (Option 1)**: A tricyclic antidepressant (TCA) effective for OCD and anxiety disorders. However, SSRIs are first-line for SAD due to better tolerability and efficacy. Clomipramine’s side effects (e.g., anticholinergic effects) make it less ideal for adolescents.  
- **Phenelzine (Option 2)**: A monoamine oxidase inhibitor (MAOI) used for treatment-resistant depression. It carries dietary restrictions and risks of hypertensive crises, making it unsuitable for a first-line approach in SAD.  
- **Clonazepam (Option 3)**: A benzodiazepine that alleviates acute anxiety. However, benzodiazepines are not recommended for long-term use in adolescents due to dependency risks and lack of efficacy for underlying social anxiety.  
- **Fluoxetine (Option 4)**: A selective serotonin reuptake inhibitor (SSRI) and first-line pharmacotherapy for SAD in adolescents. It addresses both anxiety and avoidance behaviors with proven efficacy and safety in this age group.  
- **Propranolol (Option 5)**: A beta-blocker that reduces physiological symptoms (e.g., tremors, tachycardia) but does not address core anxiety or avoidance. It is only useful for short-term, event-specific use (e.g., presentations) and not a standalone treatment.  

**4. Final Selection**  
**My final selection is: Option 4 (Fluoxetine) (氟西汀)**  

**Key Evidence Supporting Choice**:  
- Fluoxetine is an SSRI, the gold-standard first-line pharmacotherapy for social anxiety disorder in adolescents.  
- It effectively reduces both psychological symptoms (anxiety, fear of judgment) and behavioral avoidance.  
- It is FDA-approved for pediatric use and has a favorable safety profile compared to other options.  
- Other agents (e.g., clonazepam, propranolol) address only specific symptoms or carry significant risks, making them less suitable for long-term management.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 4 (Fluoxetine)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient**: 15-year-old girl with worsening academic performance and social withdrawal over the past year.  
- **Chief Complaint**: Anxiety in social/academic settings, avoidance behaviors, and physical symptoms (tachycardia, flushing).  
- **Key Symptoms**:  
  - Persistent fear of negative evaluation by peers (e.g., being called "stupid").  
  - Avoidance of class participation and social interactions (e.g., hiding in restrooms).  
  - Acute anxiety during a presentation (tachycardia, flushing).  
  - Avoidant eye contact and observable anxiety on mental status exam.  
  - No physical/neurologic abnormalities.  

**2. Analysis of Clinical Features**  
- **Timeline**: Symptoms began with high school transition (social/academic stressors) and escalated after a traumatic presentation.  
- **Core Features**:  
  - Excessive fear of embarrassment/scrutiny (DSM-5 criterion for **social anxiety disorder**).  
  - Avoidance of social situations and anticipatory anxiety.  
  - Physical symptoms (autonomic hyperactivity) during exposure.  
- **Supporting Diagnosis**:  
  - Symptoms align with **social anxiety disorder (SAD)**, particularly generalized subtype.  
  - Absence of mood disorder symptoms (e.g., anhedonia, low mood) or psychotic features.  

**3. Differential Diagnosis Analysis**  
1. **Clomipramine (TCA)**:  
   - Primarily used for OCD/depression. Less effective for SAD; anticholinergic side effects make it suboptimal for adolescents.  
2. **Phenelzine (MAOI)**:  
   - Effective for SAD but restricted by dietary interactions and safety concerns in adolescents. Second-line if SSRIs fail.  
3. **Clonazepam (Benzodiazepine)**:  
   - Rapid anxiolysis but risk of dependence/tolerance. Not ideal for chronic management in adolescents.  
4. **Fluoxetine (SSRI)**:  
   - **First-line for SAD** (SSRIs are guideline-recommended). Proven efficacy in adolescents, improves core anxiety/avoidance.  
5. **Propranolol (Beta-blocker)**:  
   - Addresses situational physical symptoms (e.g., tachycardia) but does not treat underlying anxiety.  

**4. Final Selection**  
**My final selection is: Option 4 (Fluoxetine)(氟西汀)**  
- **Key Evidence**:  
  - Fluoxetine is an SSRI, the **first-line pharmacotherapy for social anxiety disorder** per guidelines (e.g., APA, NICE).  
  - SSRIs target core symptoms (anxiety, avoidance) and are safer for long-term use in adolescents compared to benzodiazepines or MAOIs.  
  - The patient’s chronic anxiety, avoidance, and functional impairment (academic decline) warrant SSRI initiation.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 4 (Fluoxetine)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option4

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option4 - Fluoxetine
Correct Answer: - Fluoxetine

Is the final diagnosis correct? ✓ Correct

